$2.53
arrow_drop_down2.69%Key Stats | |
---|---|
Open | $2.68 |
Prev. Close | $2.60 |
EPS | -1.62 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $64.07M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.51 | 2.71 |
52 Week Range | 0.82 | 5.99 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.62 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
MAIA Soars 20% on Interim Results From Lung Cancer Study
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket